Henry Masur

60.4k citations

375 papers · 33.5k indexed · 11 hit papers · h-index 88

Virology top 0.05%
- HIV Research and Treatment 68
Emergency Medical Services top 0.01%
Critical Care and Intensive Care Medicine top 0.05%
Infectious Diseases top 0.02%
- HIV/AIDS drug development and treatment 80
- HIV/AIDS Research and Interventions 57
- Tuberculosis Research and Epidemiology 52
Epidemiology top 0.01%
- Pneumocystis jirovecii pneumonia detection and treatment 131
- Cytomegalovirus and herpesvirus research 39
Hepatology
- Hepatitis C virus research 66
Immunology
- Immune Cell Function and Interaction 33

Co-authors: Joseph A. Kovacs H. Clifford Lane Naomi P. O’Grady Anthony S. Fauci Issam Raad Michele L. Pearson Adrienne G. Randolph Mary Alexander
Cited by: Virology Emergency Medical Services Critical Care and Intensive Care Medicine
Journals: Clinical Infectious Diseases (41 papers)The Journal of Infectious Diseases (36 papers)Critical Care Medicine (21 papers)
Partner nations: United States Germany Uganda

In The Last Decade

Henry Masur

366 papers receiving 31.5k citations

Hit Papers

11 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Clinical Infectious Diseases
2011 Clinical Infectious Diseases
2011 American Journal of Infection Control
2009 PsycEXTRA Dataset
2004 Intensive Care Medicine
2004 Critical Care Medicine
2002 Infection Control and Hospital Epidemiology
1999 Proceedings of the National Academy of Sciences
1988 Nature
1983 New England Journal of Medicine
1981 New England Journal of Medicine

Peers

Countries citing papers authored by Henry Masur

Since Specialization

Citations

This map shows the geographic impact of Henry Masur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Masur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Masur more than expected).

Fields of papers citing papers by Henry Masur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Masur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Masur. The network helps show where Henry Masur may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henry Masur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Masur Line = papers co-authored together Henry Masur links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth Open Forum Infectious Diseases ·Omar Harfouch,Andrea Lisco,Dorothy. Benning,Mohammad Hossien Feiz Haddad,Ashley Davis,Sisay Degefa Bedada,L. Mihaila,Tomizo Yamamoto,LU Shuai-shua,Rachel Silk,David Sternberg,Huilin Que,八郎,Julia Erbrech,Armer Cc,Henry Masur,Shyamasundaran Kottilil,Sarah Kattakuzhy,Elana Rosenthal	2024	2
2	Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper Clinical Infectious Diseases ·Chanu Rhee,Jeffrey R. Strich,Kathleen Chiotos,David C. Classen,Sara E. Cosgrove,G. Glioti,Emily L. Heil,Sameer S. Kadri,André C. Kalil,David N. Gilbert,Henry Masur,Edward Septimus,Daniel A. Sweeney,N Vaingankar,Dean L. Winslow,Donald M. Yealy,Michael Klompas	2023	20
3	Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19 Annals of Internal Medicine ·Safia Kuriakose,T. Ramalingom,Alice K. Pau,Eric S. Daar,Rajesh T. Gandhi,Pablo Tebas,Laura Evans,Roy M. Gulick,H. Clifford Lane,Henry Masur	2021	13
4	A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY) Journal of Hepatology ·Eleanor Wilson,Sydney Matone,Jennifer Hoffmann,顾文兴,Benjamin Emmanuel,Lydia Tang,Jennifer Husson,Joel V. Chua,Angie Price,Poonam Mathur,Elana Rosenthal,Sarah Kattakuzhy,Henry Masur,Shyam Kottilil	2019	13
5	1 ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPY Journal of Hepatology ·Lisa Feldman Barrett,M.P. Groth,D. Alman,Anu Osinusi,Anita Kohli,Eric G. Meissner,A. C. F. Beales,Amy Nelson,Michael A. Polis,Henry Masur,William T. Symonds,John McHutchinson,Shyam Kottilil	2013	13
6	IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin The Journal of Infectious Diseases ·Eric G. Meissner,Dimitra Bon,Ludmila Prokunina‐Olsson,Wei Tang,Henry Masur,Thomas R. OʼBrien,Eva Herrmann,Shyamasundaran Kottilil,A. Osinusi	2013	76
7	Sepsis: Time to reconsider the concept Critical Care Medicine ·Jean Carlet,Jonathan Cohen,Thierry Calandra,Steven M. Opal,Henry Masur	2008	67
8	Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV‐infected patients in Uganda HIV Medicine ·W Nass,Geoffrey Kabuye,Peter Mugyenyi,Jeffrey John Bradway,Ven Natarajan,LeeJae Jun,Cissy Kityo,Elizabeth Formentini,Henry Masur	2007	97
9	Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockbreakdown → Critical Care Medicine ·R. Phillip Dellinger,Jean Carlet,Henry Masur,Herwig Gerlach,Thierry Calandra,Jonathan Cohen,Juan Gea‐Banacloche,Didier Keh,John C. Marshall,Margaret M. Parker,Graham Ramsay,Janice L. Zimmerman,Jean‐Louis Vincent,Mitchell M. Levy	2004	1972
10	Guidelines for the prevention of the intravascular catheter‐related infections Nutrition in Clinical Practice ·Naomi P. O’Grady,Mary Alexander,Lillian A. Burns,E. Patchen Dellinger,Jeffrey Garland,Stephen O. Heard,Pamela A. Lipsett,Henry Masur,Leonard A. Mermel,Michele L. Pearson,Issam Raad,Adrienne G. Randolph,Mark E. Rupp,Sanjay Saint,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2003	38
11	Extensive Retinal Neovascularization as a Late Finding in Human Immunodeficiency Virus–Infected Patients with Immune Recovery Uveitis Clinical Infectious Diseases ·Mary E. Wright,Daniel L. Suzman,Karl G. Csaky,Henry Masur,Michael A. Polis,Michael R. Robinson	2003	18
12	Peripheral Choroidal Neovascularization as a Late Finding in HIV-infected Patients with Inactive Cytomegalovirus Retinitis and Ocular Inflammation from Immune Recovery Uveitis Investigative Ophthalmology & Visual Science ·Wilson Fernando García Castellanos,Nancy Hoehman,K.G. Csaky,Henry Masur,Michael A. Polis,Robinson	2002	0
13	1999 USPHS/IDSA Guidelines for the Prevention ofOpportunistic Infections in Persons Infected WithHuman Immunodeficiency Virus Infectious Diseases in Obstetrics and Gynecology ·Jonathan Kaplan,Henry Masur,King K. Holmes,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2000	3
14	Introduction to the 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus Clinical Infectious Diseases ·Henry Masur,King K. Holmes,Jonathan E. Kaplan	2000	36
15	Respiratory infections in patients with HIV Lippincott Williams & Wilkins eBooks ·Henry Masur	1999	0
16	Lack of Clinical Utility of Bronchoalveolar Lavage Cultures for Cytomegalovirus in HIV Infection American Journal of Respiratory and Critical Care Medicine ·淑儀呉,James H. Shelhamer,Henry Masur,V J Gill,William D. Travis,D. Solomon,Jody Manischewitz,Frida Stock,H. Clifford Lane,Frederick P. Ognibene	1997	25
17	Phase I/II Studies of the Toxicity and Immunogenicity of Recombinant gp160 and p24 Vaccines in HIV-Infected Individuals AIDS Research and Human Retroviruses ·Kathryn M. Zunich,H. Clifford Lane,Richard T. Davey,J Falloon,Michael A. Polis,Joseph A. Kovacs,Henry Masur	1992	6
18	Diagnosis of Pneumocystis carinii Pneumonia by Multiple Lobe, Site-directed Bronchoalveolar Lavage with Immunofluorescent Monoclonal Antibody Staining in Human Immunodeficiency Virus-infected Patients Receiving Aerosolized Pentamidine Chemoprophylaxis American Review of Respiratory Disease ·Stewart J. Levine,Daniel Kennedy,James H. Shelhamer,Andrea Kovacs,Irwin M. Feuerstein,Vee J. Gill,Frida Stock,Diane Solomon,C. Thomas Boylen,Henry Masur,Simon Nwigwe	1992	33
19	Monoclonal antibodies provide a sensitive and specific method for detecting pneumocystis in sputum Clinical research ·Joseph A. Kovacs,V J Gill,Keith Hadley,Gifford Leoung,Gerald A. Evans,J E Parrillo,Henry Masur	1987	1
20	The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. PubMed ·Liana Denise Pereira Sousa,James H. Shelhamer,V J Gill,Abe M. Macher,D Loew,Margaret M. Parker,Edward P. Gelmann,Carlos Roberto Pinheiro,J E Parrillo,Henry Masur	1984	96

About Henry Masur

Henry Masur is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 375 papers that have together received 33.5k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (131 papers), HIV/AIDS drug development and treatment (80 papers), HIV Research and Treatment (68 papers), Hepatitis C virus research (66 papers), HIV/AIDS Research and Interventions (57 papers), Tuberculosis Research and Epidemiology (52 papers), Cytomegalovirus and herpesvirus research (39 papers) and Immune Cell Function and Interaction (33 papers). The work is most often cited by research in Virology (6.1k citations), Emergency Medical Services (4.6k citations) and Critical Care and Intensive Care Medicine (3.1k citations). Henry Masur has collaborated with scholars based in United States, Germany and Uganda. Frequent co-authors include Joseph A. Kovacs, H. Clifford Lane, Naomi P. O’Grady, Anthony S. Fauci, Issam Raad, Michele L. Pearson, Adrienne G. Randolph, Mary Alexander, Leonard A. Mermel and E. Patchen Dellinger. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases, Critical Care Medicine, Annals of Internal Medicine and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact